Latest Headlines

  1. Johnson & Johnson Innovation To Join NXT Biomedical Therapeutic Device Incubator To Accelerate Medical Device Innovation
    1/8/2019

    Johnson & Johnson Innovation, LLC ("JJI") today announced it entered a definitive agreement to join NXT Biomedical Therapeutic Device Incubator ("NXT") through a strategic investment facilitated by Johnson & Johnson Innovation – JJDC

  2. FDA Clears Grifols’ Automated Benchtop Analyzer
    1/8/2019

    Grifols, a leading producer of plasma- derived medicines and recognized leader in transfusion medicine, has received U.S. Food and Drug Administration approval of Erytra Eflexis, a fully automated, benchtop analyzer.

  3. Phosphorus Receives Laboratory Permit And Test Approvals From New York State Department Of Health
    1/8/2019

    Phosphorus, a leader in diagnostic and bioinformatic solutions for clinical Next Generation Sequencing (NGS), announced that the company's laboratory completed the Clinical Laboratory Evaluation Program (CLEP) administered by the New York State Department of Health (NYSDOH) and has been issued its clinical laboratory permit in the category Genetic Testing - Molecular

  4. Berkeley Lights Launches Plasma B Cell Antibody Discovery Workflow On The Beacon® Optofluidic Platform
    1/5/2019

    Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today the release of a plasma B cell antibody discovery workflow for use on the Beacon Optofluidic Platform

  5. Natera Obtains Z-Codes For Signatera MRD And Treatment Monitoring Test In Oncology
    1/4/2019

    Natera, Inc. (NASDAQ: NTRA), a global leader in non-invasive genetic testing and cell-free DNA, today announced the assignment of two Z-codes for the company's Signatera™ test, in preparation for its planned clinical launch in Q2 2019

  6. CIRCULOGENE Expands Molecular Diagnostics Testing Footprint To Asia-Pacific Region
    1/3/2019

    CIRCULOGENE, advancing precision medicine through molecular genetics testing, has entered into an international partnership with New Zealand-based CIRCULOGENE Asia Pacific Limited

  7. Calidi Biotherapeutics Launches Scientific And Medical Advisory Board
    1/3/2019

    Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the founding of a scientific and medical advisory board (SMAB)

  8. Fulgent Genetics And Columbia University Irving Medical Center Partner On Expanded Carrier Screening
    1/3/2019

    Fulgent Genetics (NASDAQ: FLGT) and the Precision Genomics Laboratory (PGL), in collaboration with the Department of Obstetrics and Gynecology, at Columbia University Irving Medical Center (CUIMC) announced today a new partnership to make on site performed, expanded carrier screening available to Columbia patients

  9. GENFIT And LabCorp Sign A Licensing Agreement To Expand Access To An Innovative Diagnostic Assay For Non-Alcoholic SteatoHepatitis (NASH)
    1/3/2019

    LabCorp® (NYSE: LH), a leading global life sciences company, and GENFIT (Euronext: GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, have announced the signing of a licensing agreement between GENFIT and Covance, LabCorp's drug development business

  10. uBiome Completes ISO 15189 Assessment, Internationally-Recognized Clinical Testing Accreditation
    1/3/2019

    uBiome, the leader in microbial genomics, announces it expects to receive ISO 15189 Accreditation for Clinical Testing Laboratories, which establishes requirements for medical laboratories to demonstrate competence to deliver timely, accurate, and reliable results to an international standard